Literature DB >> 17175381

Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.

Rahel Schaub1, Alexa Burger, Damaris Bausch, Felix K Niggli, Beat W Schäfer, David R Betts.   

Abstract

Wilms tumor (WT) is one of the most common solid tumors in childhood. It is characterized by a nonrandom pattern of chromosomal aberrations whose clinical significance is still uncertain. To gain further insight into different genetic events and their corresponding biological role, conventional cytogenetics and array comparative genomic hybridization (array CGH) were performed on 13 tumor samples. In two of these, array CGH revealed, together with other aberrations, a low-level amplification and an unbalanced gain in the region of chromosome bands 2p23 approximately p24 that encompass the MYCN gene. Both events were confirmed with a MYCN-specific fluorescence in situ hybridization probe, which showed a signal pattern consistent with a small homogenous staining region in one case. In addition, mRNA expression levels for MYCN were determined by quantitative reverse-transcriptase polymerase chain reaction and revealed that gain of chromosomal material was reflected in enhanced levels of MYCN mRNA in both tumors, whereby also additional tumors showed increased MYCN expression. Therefore, our findings suggest that WT is an additional childhood tumor where MYCN gain might play an important role in tumor development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17175381     DOI: 10.1016/j.cancergencyto.2006.08.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Functional Enhancers Shape Extrachromosomal Oncogene Amplifications.

Authors:  Andrew R Morton; Nergiz Dogan-Artun; Zachary J Faber; Graham MacLeod; Cynthia F Bartels; Megan S Piazza; Kevin C Allan; Stephen C Mack; Xiuxing Wang; Ryan C Gimple; Qiulian Wu; Brian P Rubin; Shashirekha Shetty; Stephane Angers; Peter B Dirks; Richard C Sallari; Mathieu Lupien; Jeremy N Rich; Peter C Scacheri
Journal:  Cell       Date:  2019-11-21       Impact factor: 41.582

2.  Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Authors:  Richard D Williams; Reem Al-Saadi; Tasnim Chagtai; Sergey Popov; Boo Messahel; Neil Sebire; Manfred Gessler; Jenny Wegert; Norbert Graf; Ivo Leuschner; Mike Hubank; Chris Jones; Gordan Vujanic; Kathy Pritchard-Jones
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

3.  Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.

Authors:  Ming-Ru Chiang; Chi-Wen Kuo; Wen-Chung Wang; Tai-Cheng Hou; Chen-Yun Kuo; Meng-Yao Lu; Yen-Chein Lai
Journal:  Pathol Oncol Res       Date:  2019-01-23       Impact factor: 3.201

4.  A genome-wide association study identifies susceptibility loci for Wilms tumor.

Authors:  Clare Turnbull; Elizabeth R Perdeaux; David Pernet; Arlene Naranjo; Anthony Renwick; Sheila Seal; Rosa Maria Munoz-Xicola; Sandra Hanks; Ingrid Slade; Anna Zachariou; Margaret Warren-Perry; Elise Ruark; Mary Gerrard; Juliet Hale; Martin Hewitt; Janice Kohler; Sheila Lane; Gill Levitt; Mabrook Madi; Bruce Morland; Veronica Neefjes; James Nicholson; Susan Picton; Barry Pizer; Milind Ronghe; Michael Stevens; Heidi Traunecker; Charles A Stiller; Kathy Pritchard-Jones; Jeffrey Dome; Paul Grundy; Nazneen Rahman
Journal:  Nat Genet       Date:  2012-04-29       Impact factor: 38.330

5.  Genetic and chromosomal alterations in Kenyan Wilms Tumor.

Authors:  Harold N Lovvorn; Janene Pierce; Jaime Libes; Bingshan Li; Qiang Wei; Hernan Correa; Julia Gouffon; Peter E Clark; Jason R Axt; Erik Hansen; Mark Newton; James A O'Neill
Journal:  Genes Chromosomes Cancer       Date:  2015-08-14       Impact factor: 5.006

6.  Multiple mechanisms of MYCN dysregulation in Wilms tumour.

Authors:  Richard D Williams; Tasnim Chagtai; Marisa Alcaide-German; John Apps; Jenny Wegert; Sergey Popov; Gordan Vujanic; Harm van Tinteren; Marry M van den Heuvel-Eibrink; Marcel Kool; Jan de Kraker; David Gisselsson; Norbert Graf; Manfred Gessler; Kathy Pritchard-Jones
Journal:  Oncotarget       Date:  2015-03-30

Review 7.  Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review.

Authors:  Changkai Deng; Rong Dai; Xuliang Li; Feng Liu
Journal:  Cancer Sci       Date:  2016-03-18       Impact factor: 6.716

Review 8.  Biological Drivers of Wilms Tumor Prognosis and Treatment.

Authors:  Hannah M Phelps; Saara Kaviany; Scott C Borinstein; Harold N Lovvorn
Journal:  Children (Basel)       Date:  2018-10-26

9.  Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of CHEK2 in Wilms tumour susceptibility.

Authors:  Sara Ciceri; Beatrice Gamba; Paola Corbetta; Patrizia Mondini; Monica Terenziani; Serena Catania; Marilina Nantron; Maurizio Bianchi; Paolo D'Angelo; Federica Torri; Fabio Macciardi; Paola Collini; Martina Di Martino; Fraia Melchionda; Andrea Di Cataldo; Filippo Spreafico; Paolo Radice; Daniela Perotti
Journal:  Oncotarget       Date:  2018-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.